Status:
COMPLETED
Imaging of Islet Transplantation With PET and MRT
Lead Sponsor:
Uppsala University Hospital
Conditions:
Islet Transplantation
Diabetes Type 1
Eligibility:
All Genders
18-60 years
Brief Summary
Islets of Langerhans intended for clinical transplantation are labelled with a radioactive tracer. The tracer is retained in viable cells of the transplant. At infusion (transplantation) of the islets...
Detailed Description
Background: It is suspected that the current need for repeated islets transplantation to treat diabetes type I is dependent on an early destruction of the islets when infused into the portal vein. A...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients suitable for clinical islet transplantation.
- Patient on waiting list for islet transplantation within the Nordic Network for Clinical Islet Transplantation
- Written Informed Concent
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00417131
Start Date
October 1 2006
End Date
November 1 2010
Last Update
August 4 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital, Dept. of Transplantation surgery
Stockholm, Sweden, S-141 86
2
Uppsala University Hospital, Dept of Transplantation Surgery
Uppsala, Sweden, S-751 85